References
- Pisetsky DS, Gladman DF, Urowitz MB, et al. Systemic lupus erythematosus. In: Schumacher HR, Klippel JH, Koopman WJ, eds. Primer on the rheumatic diseases. 10th ed. Atlanta, Ga: Arthritis Foundation, 1993: 100–5
- Malinow MR, Bardana EJ Jr, Goodnight SH Jr. Pancytopenia during ingestion of alfalfa seeds. (Letter) Lancet 1981; 1(8220 Pt 1): 615
- Malinow MR, Bardana EJ Jr, Pirofeky B, et al. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 1982: 216(4544): 415–7
- Petri M. Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 1994; 6(5): 481–6
- Asherson RA, Liote F, Page B, et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1993; 20(2): 284–8
- Petri M, Baker J, Goldman D. Risk factors for avascular necrosis in SLE. Arthritis Rheum 1992; 35(suppl): Sl 10
- Petri M, Lakatta C, Magder L, et al. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994; 96(3): 254–9
- Ginzler EM, Felson DT, Anthony JM, et al. Hypertension increases the risk of renal deterioration in systemic lupus erythematosus. J Rheumatol 1993: 20(10): 1694–700
- Gladman DD, Urowitz MB, Cole E, et al. Kidney biopsy in SLE. I. A clinical-morphologic evaluation. QJ Med 1989: 73(272): 1125–33
- Goulet JR, MacKenzie T, Levinton C, et al. The longterm prognosis of lupus nephritis: the impact of disease activity. J Rheumatol 1993; 20(l): 59–65
- Esdaile JM, Abrahamowicz M, MacKenzie T, et al. The time-dependence of long-term prediction in lupus nephritis. Arthritis Rheum 1994; 37(3): 359–68
- Gladman DD, Urowitz MB. Systemic lupus erythematosus. B. Clinical features. In: Schumacher et al, eds,1 pp 106–11
- Laroche CM, Mulrey DA, Hawkins PN, et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. QJ Med 1989: 71(265): 429–39
- Schneebaum AB, Singleton JD, West SG, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991; 90(I): 54–62
- West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994; 20(l): 129–58
- Brandt KD, Lessell S. Migrainous phenomena in systemic lupus erythematosus. Arthritis Rheum 1978; 21(1): 7–16
- Isenberg DA, Meyrick-Thomas D, Snaith ML, et al. A study of migraine in systemic lupus erythematosus. Ann Rheum Dis 1982; 41(l): 30–2
- Bhalla R, Ajmani HS, Kim WW, et al. Systemic lupus erythematosus and Hodgkin's lymphoma. J Rheumatol 1993; 20(8): 1316–20
- Pryor B, Bologna S, Ernst C, et al. Risk of malignancy in cyclophosphamide-treated SLE patients. Arthritis Rheum 1993: 36(9 Suppl): S91